Affera Global Registry
Recruiting
Observational Study
Atrial Fibrillation
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 540 (estimated)
- Sponsor
- Medtronic Cardiac Ablation Solutions · Industry
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The Affera Global Registry is a prospective, global, multi-center, observational post-market registry (PMR). The purpose of this study is to describe clinical performance and safety data in a broad patient population treated with the Affera Platform.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Subject is ≥ 18 years of age or minimum age as required by local regulations
* Planned procedure using the commercially available Affera Platform
* Willing and able to comply with study requirements and give IC (defined as legally effective, documented confirmation of a subjec…
Contacts